Pucotenlimab Combined with MRG002 for HER2-positive Cancer of Unknown Primary
Clinical trial NCT06869174 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06869174
- Sponsor
- Zhiguo Luo, MD, PhD
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-08
- Primary completion
- 2027-03-08
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.